
Work Here?
FIGS, Inc. sells high-quality scrubs and lifestyle apparel directly to healthcare professionals through the largest direct-to-consumer platform in healthcare apparel. Their products are designed for comfort, durability, function, and style, aiming to improve the work experience for doctors, nurses, and medical staff. The company operates a DTC model to maintain control over brand and customer experience while offering competitive prices and strong margins. FIGS differentiates itself from competitors through its founder-led approach, direct customer access, and a focus on technically informed apparel tailored to medical professionals, backed by active social media marketing and community building. The goal is to redefine healthcare apparel by delivering reliable, fashionable workwear that meets the needs of healthcare workers and to grow a loyal, engaged customer community.
Industries
Healthcare
Consumer Goods
Company Size
201-500
Company Stage
IPO
Headquarters
Culver City, California
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$653M
Above
Industry Average
Funded Over
4 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Paid Vacation
Parental Leave
Wellness Program
Employee Discounts
FIGS stock surges after big earnings beat and upgraded outlook. TIM SYKES - UPDATED AUG. 9, 2026, 10:08 AM ET FIGS Inc. stocks have been trading up by 28.71 percent, propelled by upbeat news signaling strengthening demand and investor confidence. What traders need to know. * Q2 earnings smashed expectations with EPS of $0.15 vs $0.07 and revenue of $196.6M vs $186.1M, delivering a third straight quarter of 25%+ net revenue growth and 18.6% EBITDA margin. * Management raised its FY26 outlook to about 20% revenue growth and lifted the adjusted EBITDA margin target to 14.8%-15% from 13%-13.2%. * Shares of FIGS Inc. jumped nearly 28% after the Q2 beat, with strong year-over-year growth and better profitability sparking aggressive buying. * Multiple firms, including BTIG, KeyBanc, Barclays, Roth Capital, and Goldman Sachs, raised price targets on FIGS after the report, several reiterating Buy or Overweight ratings. * One counterpoint came from Telsey Advisory, which trimmed its target to $16 and kept a Market Perform rating, flagging macro and supply chain risks despite the strong quarter. Weekly Update Aug 03 - Aug 07, 2026: On Sunday, August 09, 2026 FIGS Inc. stock [NYSE: FIGS] is trending up by 28.71%! Discover the key drivers behind this movement as well as its expert analysis in the detailed breakdown below. Consumer Discretionary industry expert: Analyst sentiment - positive FIGS stands as a scaled, profitable niche leader in premium medical apparel, combining DTC DNA with increasingly diversified channels. Revenue of ~$631M with mid-teens multi-year CAGR, gross margin of 66.6%, and Q2 EBIT margin above the 6.1% full-year level underscore strong unit economics. Returns on equity around 10% and ROIC ~6% are healthy for an asset-light model, while leverage is negligible (D/E 0.14, current ratio 5.4). Free cash flow of ~$44M in Q2 supports continued reinvestment and optionality around capital returns. Technically, FIGS has shifted decisively into a momentum uptrend. This week's move from ~$11 to $14.47, with the 8/6 gap and expansion candle on heavy volume, confirms a breakout from a multi-month base. Intraday 5-minute action shows persistent dip-buying above $13.50 with rising volume into the close, signaling strong institutional demand. For traders, $13.80-14.00 is the critical first support; a sustained hold above this zone favors a measured long with a tight stop just below $13.40. Fundamentally and relative to Consumer Discretionary and Apparel & Luxury peers, FIGS screens as a premium-multiple growth compounder. Three consecutive quarters of 25%+ net revenue growth, Q2 EPS beat (0.15 vs 0.07), and EBITDA margin expansion to ~18.6% justify its high P/E versus slower-growing apparel names. Raised FY26 guidance (≈20% revenue growth, higher margin targets) plus multiple Buy-rated PT hikes support further re-rating. I see near-term resistance at $16.50-17 and an achievable 6-12 month target of $20. Quick financial overview. FIGS Inc. delivered a clean beat in Q2, printing $196.6M in revenue versus roughly $186M expected and EPS of $0.15 versus $0.07. That put net revenue growth north of 25% for the third quarter in a row and pushed adjusted EBITDA margin to 18.6%, a strong level for an apparel-focused brand. With gross margin around 66.6% and profit margin in the mid-single digits, the model is clearly built on high product markup and ongoing operating leverage. From a balance sheet view, FIGS Inc. carries modest leverage, with total debt to equity at 0.14 and a current ratio of 5.4. Cash and short-term investments sit comfortably above $250M, and Q2 free cash flow of about $44.3M shows the brand is converting earnings into cash. Returns on equity and assets are positive and improving, helped by asset turnover of 1.2, which tells traders the business is using its asset base fairly efficiently for a growth story. On the tape, the Q2 report acted like a reset. Weekly data show FIGS stock grinding near $11 before the release, then exploding to a $14.90 high and holding above $14 into the week's close. Intraday, price spiked from the low teens to above $16.30 before backing off to the mid-$14s, a classic earnings gap plus run with some profit-taking. With a price-to-sales ratio near 3.6 and a rich P/E near 67.9, the stock is priced for continued growth, which puts extra weight on each future quarter for momentum traders. Conclusion. This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Its content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to Millionaire Media, LLC. for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize its news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities. Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles: Once you've got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market's twists and turns. Dig into StocksToTrade's watchlists here: Buy this stock for a monster Monday move. Want to start next week off with a big win? Its new algorithm may have just uncovered a new dirt-cheap stock with a great chance of moving +100% or more this Monday. ...One ticker...One trade...One MONSTER move... All you have to do is make this one trade on Monday. While I can't promise future performance, previous picks from this new Monday Algo have racked up gains of +149%, +190%, and +536%... in as little as one day. And Millionaire Media, LLC. think this new pick could be just as big. But if Millionaire Media, LLC. is right, it may move FAST... How much has this post helped you? (0 votes, average: 0 out of 5)
Healthcare apparel company Figs reported second-quarter 2026 results that exceeded analyst expectations. Revenue grew 28.8% year-on-year to $196.6 million, surpassing estimates of $186.1 million. The company's GAAP earnings per share of $0.15 significantly beat analyst estimates of $0.07. Adjusted EBITDA reached $36.59 million, representing an 18.6% margin and a 45.3% beat against expectations of $25.18 million. Operating margin improved to 17.9%, up from 6.5% in the same quarter last year. Free cash flow turned positive at $44.26 million, compared with negative $13.52 million in the prior year period. Figs' active customer base grew to 3.1 million, an increase of 360,000 year-on-year. Following the results, the company's stock price jumped 25.1%.
Made for the moment: FIGS and Marvel partner to launch exclusive Spider-Man Collection. (C) 2026 MARVEL Tl;dr: - FIGS and Marvel have teamed up to launch an exclusive Spider-Man collection, inspired by healthcare professionals who know exactly when and how to show up. - Available in NEW Mauritius Blue and Hibiscus, the collection features fresh limited-edition and best-selling Marvel Spider-Man styles. FIGS | Marvel Spider-Man Collection: limited-edition and best-selling styles swing into action. FIGS and Marvel are joining forces to launch the exclusive Marvel | FIGS Spider-Man Collection, inspired by those whose greatness comes from within (no spider bite required). Engineered for friendly neighborhood Awesome Humans, the collection celebrates the courage, selflessness, and skill that define healthcare professionals. Arriving on the scene are NEW Mauritius Blue and Hibiscus in fresh limited-edition and best-selling styles. The collection blends bold color and original Spider-Man details with the unmatched comfort, performance, and functionality healthcare professionals expect from FIGS. Featuring proprietary FIONx(TM) fabric - lightweight, durable, and ridiculously soft - plus thoughtful details and ample pockets, every piece is designed for nonstop action. Because saving lives is a job that never stops.
July 1, 2026. Iconic styles, new waistbands: FIGS launches best-selling scrub pants with ruched waistbands. Tl;dr: - FIGS introduces a new mid-rise fit with an adjustable ruched waistband in three best-selling scrub pant styles - giving healthcare professionals more choice in how they wear and style their daily uniform. - Created in response to customer demand for additional fit options, the new silhouette offers customizable comfort and greater versatility, and launches in three Core colors: Black, Navy, and Moss. Always-Iconic styles - now available with ruched waistbands. FIGS expands their scrub pant offering with the launch of their best-selling Isabel, Livingston, and Zamora styles - in a fresh new mid-rise fit and a comfortable, adjustable ruched waistband. This all-new mid-rise silhouette will be released in three of FIGS' most popular Core colors: Black, Navy, and Moss. This highly-requested waistband expansion provides increased optionality for healthcare professionals' daily uniform - adding more versatility to their wardrobe, and encouraging greater customized comfort and style for Awesome Humans everywhere.
Black Creek Investment Management Inc. sells 238,730 Shares of FIGS, Inc. $FIGS. June 14, 2026 Key points. * Black Creek Investment Management cut its FIGS stake by 16.6% in the fourth quarter, selling 238,730 shares and leaving it with 1,195,961 shares valued at about $13.6 million. * FIGS beat earnings and revenue expectations in its latest quarterly report, posting $0.03 EPS versus $0.01 expected and revenue of $159.9 million, up 28% year over year. * Analysts remain generally constructive on the stock, with a consensus rating of "Moderate Buy" and an average price target of $15.93, even as some firms recently downgraded or adjusted their views. * Interested in FIGS? Here are five stocks we like better. Black Creek Investment Management Inc. trimmed its holdings in FIGS, Inc. (NYSE:FIGS - Free Report) by 16.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,195,961 shares of the company's stock after selling 238,730 shares during the quarter. FIGS comprises about 0.7% of Black Creek Investment Management Inc.'s investment portfolio, making the stock its 19th biggest holding. Black Creek Investment Management Inc. owned about 0.73% of FIGS worth $13,586,000 at the end of the most recent quarter. Several other institutional investors also recently modified their holdings of the business. FourThought Financial Partners LLC increased its stake in shares of FIGS by 3.6% in the 4th quarter. FourThought Financial Partners LLC now owns 32,851 shares of the company's stock worth $373,000 after acquiring an additional 1,138 shares in the last quarter. GSA Capital Partners LLP increased its stake in FIGS by 4.2% during the 3rd quarter. GSA Capital Partners LLP now owns 52,045 shares of the company's stock valued at $348,000 after purchasing an additional 2,083 shares in the last quarter. Corient Private Wealth LLC increased its stake in FIGS by 0.8% during the 2nd quarter. Corient Private Wealth LLC now owns 332,938 shares of the company's stock valued at $1,878,000 after purchasing an additional 2,612 shares in the last quarter. Creative Planning increased its stake in FIGS by 4.9% during the 3rd quarter. Creative Planning now owns 68,932 shares of the company's stock valued at $461,000 after purchasing an additional 3,192 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in FIGS by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,219 shares of the company's stock valued at $354,000 after purchasing an additional 3,276 shares in the last quarter. 92.21% of the stock is currently owned by institutional investors. Analyst ratings changes. A number of analysts have weighed in on FIGS shares. BTIG Research restated a "buy" rating and set a $20.00 price objective on shares of FIGS in a research note on Friday, April 24th. Zacks Research lowered shares of FIGS from a "strong-buy" rating to a "hold" rating in a research note on Friday, May 8th. Barclays upgraded shares of FIGS from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 27th. Morgan Stanley raised their price objective on shares of FIGS from $8.00 to $15.00 and gave the company an "equal weight" rating in a research note on Monday, April 13th. Finally, Oppenheimer upgraded shares of FIGS from a "market perform" rating to an "outperform" rating and set a $22.00 price objective for the company in a research note on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, FIGS currently has a consensus rating of "Moderate Buy" and a consensus price target of $15.93. Discover more Live News Feed EV Market Report ETF Screener Access FIGS stock up 6.0%. Shares of NYSE FIGS opened at $11.96 on Friday. The firm's 50-day moving average price is $13.42 and its 200-day moving average price is $12.70. The company has a market cap of $2.00 billion, a PE ratio of 54.37 and a beta of 1.04. FIGS, Inc. has a 52-week low of $4.98 and a 52-week high of $17.48. FIGS (NYSE:FIGS - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.02. FIGS had a net margin of 6.10% and a return on equity of 9.69%. The business had revenue of $159.90 million for the quarter, compared to the consensus estimate of $153.15 million. The business's quarterly revenue was up 28.0% compared to the same quarter last year. As a group, equities research analysts anticipate that FIGS, Inc. will post 0.25 EPS for the current fiscal year. Insider buying and selling at FIGS. In other news, CEO Catherine Eva Spear sold 62,335 shares of FIGS stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $14.44, for a total transaction of $900,117.40. Following the sale, the chief executive officer owned 1,794,964 shares in the company, valued at $25,919,280.16. This trade represents a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Heather L. Hasson sold 32,385 shares of FIGS stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $14.33, for a total transaction of $464,077.05. Following the sale, the chairman owned 1,433,807 shares in the company, valued at approximately $20,546,454.31. The trade was a 2.21% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 129,189 shares of company stock valued at $1,859,331 over the last 90 days. 27.06% of the stock is currently owned by corporate insiders. FIGS company profile. FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets. Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider FIGS, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list. While FIGS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Find jobs on Simplify and start your career today
Industries
Healthcare
Consumer Goods
Company Size
201-500
Company Stage
IPO
Headquarters
Culver City, California
Founded
2013
Find jobs on Simplify and start your career today